Category: Latest News
-
Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance
Exagen (NASDAQ:XGN) delivered record quarterly revenue, narrowed losses, improved adjusted EBITDA, and increased its full-year revenue outlook as demand for its autoimmune testing portfolio continued to grow. Key Investor Takeaways Why XGN Stock Is in Focus Exagen (NASDAQ:XGN) reported record second-quarter 2026 revenue of $19.9 million, representing a 16% increase from the same period last…
-
Corvex Signs Multi-Year NVIDIA Blackwell GPU Agreement Without Additional Equity Issuance
Corvex (NASDAQ:MOVE) secured a multi-year agreement to provide NVIDIA Blackwell GPU infrastructure, funding the expansion through debt, customer prepayments, and existing cash rather than issuing new shares. Key Investor Takeaways Why MOVE Stock Is in Focus Corvex (NASDAQ:MOVE) announced a multi-year agreement to provide clusters of NVIDIA Blackwell GPUs connected through NVIDIA Quantum-2 InfiniBand networking…
-
TNL Mediagene Expands AI Services Through Miro Partnership in Japan
TNL Mediagene (NASDAQ:TNMG) has partnered with Miro to deliver AI-powered organizational design and human resource development solutions for enterprise customers in Japan, supporting the company’s digital studio growth strategy. Key Investor Takeaways Why TNMG Stock Is in Focus TNL Mediagene (NASDAQ:TNMG) announced that its wholly owned subsidiary, Infobahn, has entered into a strategic partnership with…
-
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion
Autonomix Medical (NASDAQ:AMIX) expanded its intellectual property portfolio with a new U.S. patent covering technologies for nerve sensing, mapping, and targeted neuromodulation across multiple disease applications. Key Investor Takeaways Why AMIX Stock Is in Focus Autonomix Medical (NASDAQ:AMIX) announced the issuance of U.S. Patent No. 12,433,670, titled “Systems and Methods for Treating Cancer and/or Augmenting…
-
Bruker Reports Second-Quarter 2026 Results as Scientific Instruments Bookings Accelerate
Bruker (NASDAQ:BRKR) returned to organic revenue growth in the second quarter, posted stronger bookings across its Scientific Instruments business, and maintained its earnings outlook while adjusting guidance for currency and tax changes. Key Investor Takeaways Why BRKR Stock Is in Focus Bruker (NASDAQ:BRKR) reported second-quarter 2026 revenue of $838.5 million, up 5.2% year over year,…
-
Zebra Technologies Reports Record Second-Quarter 2026 Results and Raises Full-Year Outlook
Zebra Technologies (NASDAQ:ZBRA) posted record second-quarter performance driven by broad-based growth across its business and increased its full-year guidance as demand for automation and AI solutions remained strong. Key Investor Takeaways Why ZBRA Stock Is in Focus Zebra Technologies (NASDAQ:ZBRA) reported record financial results for the second quarter of 2026, highlighting continued demand for its…
-
Westlake Chemical Partners Misses Revenue Expectations in Second Quarter
Westlake Chemical Partners LP (NYSE:WLKP) reported second-quarter 2026 results that came in slightly below Wall Street expectations, as revenue missed forecasts and earnings narrowly fell short of analyst estimates. The partnership’s units were little changed in after-hours trading following the announcement. Revenue and Earnings Fall Short of Forecasts Westlake Chemical Partners reported earnings of $0.40…
-
Westlake Shares Rise After Second-Quarter Earnings Beat Expectations
Westlake Corporation (NYSE:WLK) reported second-quarter 2026 results that exceeded Wall Street forecasts, supported by stronger profitability in its Performance and Essential Materials business. The better-than-expected performance lifted the company’s shares 2.78% in pre-market trading. Revenue and Earnings Top Estimates Westlake posted adjusted earnings of $2.01 per share, ahead of the analyst consensus estimate of $1.86.…
-
Aptiv Shares Decline as Weak Guidance Overshadows Second-Quarter Earnings Beat
Aptiv PLC (NYSE:APTV) reported second-quarter 2026 results that exceeded Wall Street earnings expectations, but its shares fell nearly 4% in pre-market trading after the company issued weaker-than-expected guidance for both the third quarter and the full year. While quarterly performance was solid, investors focused on the softer outlook. Earnings Beat Expectations as Revenue Meets Forecasts…
-
Apollo Global Management Shares Rise as Revenue Surges Despite Earnings Miss
Apollo Global Management, Inc. (NYSE:APO) reported second-quarter 2026 results that featured stronger-than-expected revenue, although earnings came in slightly below Wall Street forecasts. Despite the earnings miss, investors responded positively to the company’s record fee growth and expanding assets under management, sending the stock 2.67% higher in pre-market trading. Revenue Tops Expectations While EPS Falls Short…